Development of the endocrine hypothalamus involves the formation of specific nuclei, characterized by production of specific neuropeptides, in which phenotypes of component cells appear in a spatially distinct fashion. These nuclei are regulated by the actions of nuclear receptors and by class III POU domain factors, and also by the actions of specific signaling molecules. In the current grant period, the applicant investigated transcriptional control of terminal differentiation of the endocrine hypothalamus and identified several novel factors hypothesized to serve as specific nuclear receptor coregulators. A ligand-dependent switch of a histone deacetylase-containing corepressor complex for a histone/factor acetyltransferase containing coactivator complex was suggested, and several structural aspects of the underlying protein-protein interactions were defined. In this competitive renewal, the applicant proposes to begin to elucidate the putative signaling gradients that may be required for the sequential determination and differentiation events that mediate the generation of specific cell phenotypes in the endocrine hypothalamus. The potential combinatorial roles of a family of related transcriptional factors in early and late developmental events in the hypothalamus will be defined, as will the physiological role of several novel factors. The in vivo role of specific components of nuclear receptor corepressors and coactivators will be explored, and their regulation will be analyzed. The role of a novel type of """"""""cosynergy"""""""" factor that may alter function of the enzymatic activities in the coactivator complex will also be examined. It is predicted that these investigations should permit further insights into both the molecular mechanisms by which the endocrine hypothalamus is established and the molecular mechanisms by which ligand-dependent transcription factors exert their positive and negative effects on gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK039949-20
Application #
6476161
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1982-08-01
Project End
2005-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
20
Fiscal Year
2002
Total Cost
$466,208
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Kim, Hong Sook; Tan, Yuliang; Ma, Wubin et al. (2018) Pluripotency factors functionally premark cell-type-restricted enhancers in ES cells. Nature 556:510-514
Wang, Jianxun; Saijo, Kaoru; Skola, Dylan et al. (2018) Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock. Proc Natl Acad Sci U S A 115:E244-E252
Tan, Yuliang; Jin, Chunyu; Ma, Wubin et al. (2018) Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program. Mol Cell 71:526-539.e8
Cardamone, Maria Dafne; Tanasa, Bogdan; Cederquist, Carly T et al. (2018) Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Mol Cell 69:757-772.e7
Yang, Feng; Ma, Qi; Liu, Zhijie et al. (2017) Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ER?-Regulated Transcriptional Program. Mol Cell 66:321-331.e6
Puc, Janusz; Aggarwal, Aneel K; Rosenfeld, Michael G (2017) Physiological functions of programmed DNA breaks in signal-induced transcription. Nat Rev Mol Cell Biol 18:471-476
Gao, Xiaofei; Lee, Hsiang-Ying; Li, Wenbo et al. (2017) Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation. Proc Natl Acad Sci U S A 114:10107-10112
Scully, Kathleen M; Skowronska-Krawczyk, Dorota; Krawczyk, Michal et al. (2016) Epithelial cell integrin ?1 is required for developmental angiogenesis in the pituitary gland. Proc Natl Acad Sci U S A 113:13408-13413
Puc, Janusz; Kozbial, Piotr; Li, Wenbo et al. (2015) Ligand-dependent enhancer activation regulated by topoisomerase-I activity. Cell 160:367-80
Li, Wenbo; Hu, Yiren; Oh, Soohwan et al. (2015) Condensin I and II Complexes License Full Estrogen Receptor ?-Dependent Enhancer Activation. Mol Cell 59:188-202

Showing the most recent 10 out of 50 publications